Mujeeb Shad, MD
Psychiatry · Las Vegas, NVNPI 1871519041
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $43,210 of the $55,170 with a category attached, or 78.3%. Alkermes, Inc. accounts for 73.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $31,755 and has fallen 97.7% since, to $724 in 2025. Among psychiatry clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $862.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$40K
- Biogen$8K
- Indivior Inc.$6K
- Neurocrine Biosciences, Inc.$1K
- Boehringer Ingelheim$292
- Lundbeck LLC$44
- plus $113 from 4 others
What the payments were for
- Consulting fees$7,78914%
- Speaking & faculty fees$43,21078%
- Travel & lodging$1,5693%
- Food & beverage$2,5885%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 37 | $40,280 |
| Biogen | 1 | $7,789 |
| Indivior Inc. | 2 | $5,523 |
| Neurocrine Biosciences, Inc. | 13 | $1,130 |
| Boehringer Ingelheim | 6 | $292 |
| Lundbeck LLC | 1 | $44 |
| E.r. Squibb & Sons, L.L.C. | 1 | $42 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$159,164
- ARISTADA INITIO$39,791
- PERSERIS$5,500
- INGREZZA$756
How this compares
$55,170 in reported general payments places this provider in the 95th percentile of 243 psychiatry providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Las Vegas
- Jelena KunovacLas Vegas$1.2M
- John AnooshianLas Vegas$836K
- Sam ZandLas Vegas$410K
- Aaron RitterLas Vegas$173K
- Mustafa RawafLas Vegas$166K
- Dylan WintLas Vegas$86K
- Dax WolfordLas Vegas$29K
- Faisal SubaLas Vegas$15K
- Ejine OkoroaforLas Vegas$13K
- John VallesLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.